Researchers at the Clínica Universidad De Navarra Identify that a Diuretic Medicine Also Slows Heart Fibrosis

diariodenavarra.es

Center

Factuality

Ownership

A study led by researchers from the Cardiovascular Research Laboratory of the Clínica Universidad de Navarra has identified new mechanisms that could explain why spironolactone, a very common diuretic drug used in relation to heart failure, also slows heart fibrosis. The results of the research, published in MedComm magazine, have been obtained using a proteomic approach and data integration using machine learning.Read more]]>

Moncloa

Factuality

Ownership

IN 30 SECONDS What has happened? A study by the Clínica Universidad de Navarra reveals a new mechanism by which the spironolactone drug stops heart fibrosis, a frequent complication of heart failure. Who is behind it? The Cardiovascular Research Laboratory of the Clínica Universidad de Navarra, a reference center in biomedicine in northern Spain. What impact does it have? The findings could improve the treatment of patients, reduce hospitalizati…